Atlas Trials

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Clinical trial NCT02537015 · COMPLETED

Trial details

NCT number
NCT02537015
Sponsor
ForSight Vision5, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Open-Angle GlaucomaOcular Hypertension
Start date
2015-08-10
Primary completion
2016-08-11
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.